Sg Americas Securities, LLC Arcus Biosciences, Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 28,497 shares of RCUS stock, worth $399,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,497

Previous 30,069 5.23%

Holding current value

$399,812

Previous $460,000 7.83%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$14.28 - $18.44 $22,448 - $28,987	-1,572 Reduced 5.23%	28,497 $424,000
Q3 2024 Oct 03, 2024	SELL	$13.69 - $18.01 $1.36 Million - $1.79 Million	-99,223 Reduced 76.74%	30,069 $460,000
Q2 2024 Jul 12, 2024	BUY	$14.59 - $18.48 $1.76 Million - $2.23 Million	120,650 Added 1396.09%	129,292 $1.97 Million
Q1 2024 May 06, 2024	SELL	$14.83 - $20.18 $176,862 - $240,666	-11,926 Reduced 57.98%	8,642 $163,000
Q4 2023 Jan 12, 2024	BUY	$13.43 - $19.63 $276,228 - $403,749	20,568 New	20,568 $393,000
Q1 2023 Apr 28, 2023	SELL	$15.96 - $23.15 $312,895 - $453,855	-19,605 Reduced 61.67%	12,184 $222,000
Q4 2022 Feb 02, 2023	BUY	$19.7 - $35.71 $626,243 - $1.14 Million	31,789 New	31,789 $657,000
Q2 2022 Jul 29, 2022	SELL	$17.23 - $37.73 $975,717 - $2.14 Million	-56,629 Reduced 60.12%	37,557 $952,000
Q1 2022 Apr 29, 2022	BUY	$28.92 - $41.83 $1.98 Million - $2.86 Million	68,297 Added 263.81%	94,186 $2.97 Million
Q4 2021 Feb 07, 2022	SELL	$31.38 - $48.47 $37,687 - $58,212	-1,201 Reduced 4.43%	25,889 $1.05 Million
Q3 2021 Nov 01, 2021	BUY	$26.93 - $37.68 $729,533 - $1.02 Million	27,090 New	27,090 $945,000
Q2 2021 Aug 12, 2021	SELL	$22.75 - $35.77 $163,822 - $257,579	-7,201 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$26.16 - $41.39 $122,114 - $193,208	-4,668 Reduced 39.33%	7,201 $202,000
Q4 2020 Feb 04, 2021	SELL	$17.0 - $32.36 $351,169 - $668,460	-20,657 Reduced 63.51%	11,869 $308,000
Q3 2020 Nov 09, 2020	BUY	$17.14 - $25.47 $306,171 - $454,970	17,863 Added 121.82%	32,526 $557,000
Q2 2020 Jul 20, 2020	BUY	$13.97 - $36.56 $41,421 - $108,400	2,965 Added 25.35%	14,663 $363,000
Q1 2020 Apr 30, 2020	BUY	$8.78 - $19.28 $102,708 - $225,537	11,698 New	11,698 $162,000
Q2 2019 Jul 29, 2019	SELL	$7.29 - $13.38 $64,020 - $117,503	-8,782 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$8.95 - $12.49 $78,598 - $109,687	8,782 New	8,782 $110,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.01B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Arcus Biosciences, Inc. Transaction History